Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds

por Chang, Grace Shu-wen, Tan, Doreen Su-Yin
Publicado 2020

Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea

por Tan, Hui Xing, Teo, Desmond Chun Hwee, Lee, Dongyun, Kim, Chungsoo, Neo, Jing Wei, Sung, Cynthia, Chahed, Haroun, Ang, Pei San, Tan, Doreen Su Yin, Park, Rae Woong, Dorajoo, Sreemanee Raaj
Publicado 2022